NASDAQ$AXON

Axon Enterprise Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Axon's revenue grew, driven by strong demand across product categories, particularly Axon Cloud software.

Axon's Q4 2023 revenue grew by 28.6% year over year, reaching $432 million, driven by strong demand across product categories. The company's net income was $57 million, or $0.75 per diluted share, while non-GAAP net income was $85 million, or $1.12 per diluted share. Axon Cloud software was the primary driver of revenue growth.

  • Quarterly revenue of $432 million exceeded expectations with 28.6% year-over-year growth.
  • Total company gross margin of 61.1% declined 10 basis points year over year.
  • Net income of $57 million, or $0.75 per diluted share, supported non-GAAP net income of $85 million, or $1.12 per diluted share.
  • Adjusted EBITDA of $91 million reflected an Adjusted EBITDA margin of 21.1%.

Headline financials

Total Revenue

$432M

Previous: $336M+28.6%
EPS (adj)

$1.12

Previous: $0.70+60.0%
Annual Recurring Revenue

$697M

Previous: $473M+47.4%
Capital Expenditures

-$24.1M

Previous: $11.6M-307.8%
Net Income

$57.3M

Previous: $29.2M+96.3%
Operating Income

$42.8M

Previous: $22.5M+89.9%
Gross Profit

$264M

Previous: $206M+28.3%
R&D Expense

$84M

No prior period
Stock-Based Comp

$35.1M

Previous: $31.7M+10.7%

Revenue & EPS history

Axon · Revenue · Quarterly

$432M

Q4 2023+28.6%vs Q4 2022
Beat estimate in 14 of 15 quarters(93%)
ActualEstimate

Revenue by segment

Axon · $163M total across 1 segment · Q3 2023

  • TASER
    $163M+12.2%

Forward guidance

Axon expects full year 2024 revenue of $1.88 billion to $1.94 billion, representing approximately 20% to 24% annual growth. Axon expects a full year 2024 Adjusted EBITDA dollars of $410 million to $430 million, implying continued Adjusted EBITDA margin expansion from 2023.

Tailwinds

  • Axon expects full year 2024 revenue of $1.88 billion to $1.94 billion, representing approximately 20% to 24% annual growth.
  • Axon expects a full year 2024 Adjusted EBITDA dollars of $410 million to $430 million, implying continued Adjusted EBITDA margin expansion from 2023.
  • We expect stock-based compensation expenses to be approximately $205 million to $220 million for the full year.
  • Full year expected stock based compensation expense includes approximately $42 million in expenses related to an enhanced equity compensation opportunity provided to employees whose compensation is under a specified threshold.
  • We expect 2024 CapEx to be in the range of $60 million to $75 million.

Headwinds

  • The following forward-looking statements reflect Axon’s expectations as of February 27, 2024, and are subject to risks and uncertainties.
  • We provide Adjusted EBITDA guidance, rather than net income guidance, due to the inherent difficulty of forecasting certain types of expenses and gains such as stock-based compensation, income tax expenses and gains or losses on marketable securities and strategic investments, which affect net income but not Adjusted EBITDA.
  • We are unable to reasonably estimate the impact of such expenses, which could be material, on net income.
  • Because our stock-based compensation expenses may vary based on changes in our stock price or the actual timing of attainment of certain metrics, it is inherently difficult to forecast future stock-based compensation expense, which may also be materially affected by any future stock-based compensation plans, subject to shareholder approval.
  • Our 2024 CapEx plans include investments in TASER 10 automation and capacity expansion, including cartridge capacity and lab enhancements and global facility build-out and upgrades, including warehousing support for global shipping facilities.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+3.4%

Avg return

Earnings day

+6.6%

Avg return

5 days after

+6.7%

Avg return

30 days after

55%

35 / 64 earnings

Positive

+31.3%

Q3 2024

Best reaction

-17.1%

Q4 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.4%+3.1%+27.9%
Q4 2025+1.1%+29.3%-2.8%
Q3 2025+13.7%-17.2%-22.0%
Q1 2025+14.2%+20.4%+31.6%
Q4 2024+15.3%+5.9%+7.7%
Q3 2024+31.3%+29.5%+49.7%
Q2 2024+22.0%+27.6%+24.0%
Q1 2024-1.8%-4.7%-11.4%
Q4 2023+13.9%+15.7%+15.2%
Q3 2023+5.9%+0.5%+8.5%
Q2 2023+11.6%+17.6%+20.3%
Q1 2023-13.1%-9.2%-12.2%
Q4 2022+13.4%+13.3%+11.7%
Q3 2022+15.8%+23.2%+15.7%
Q2 2022+8.5%+11.4%+5.6%
Q1 2022-4.0%+11.8%+15.0%
Q4 2021+9.6%+16.1%+8.4%
Q3 2021+4.3%+6.8%-13.4%
Q2 2021+0.8%-3.8%-3.3%
Q1 2021-4.6%-6.6%-0.1%
Q4 2020+2.5%+2.9%-14.6%
Q3 2020+16.7%+13.3%+18.2%
Q2 2020-9.5%-14.5%-10.8%
Q1 2020+30.2%+26.2%+40.3%
Q4 2019-3.8%-2.9%-7.5%
Q3 2019+25.0%+22.5%+37.6%
Q2 2019-11.4%-10.3%-5.4%
Q1 2019-4.9%-1.0%+3.3%
Q4 2018-4.4%-6.2%-7.2%
Q3 2018-16.1%-13.6%-26.4%
Q2 2018-10.6%-8.1%+5.1%
Q1 2018+21.6%+27.4%+41.4%
Q4 2017+23.7%+37.6%+39.6%
Q3 2017-7.7%-8.9%+4.8%
Q2 2017-10.5%-13.1%-16.4%
Q1 2017+4.8%+3.8%-2.4%
Q4 2016-6.7%-12.5%-11.0%
Q3 2016+19.3%+22.3%+6.0%
Q2 2016+1.9%-0.1%-7.5%
Q1 2016+2.9%
Q4 2015+11.2%
Q3 2015-13.8%
Q2 2015-14.1%
Q1 2015+15.3%
Q4 2014-13.2%
Q3 2014+14.4%
Q2 2014+4.9%
Q1 2014-10.7%
Q4 2013+7.3%
Q3 2013+13.5%
Q2 2013-0.2%
Q1 2013+7.8%
Q4 2012-17.1%
Q3 2012-1.7%
Q2 2012-1.1%
Q1 2012+0.0%
Q4 2011-0.5%
Q3 2010-2.7%
Q3 2011-2.7%
Q2 2010-2.7%
Q2 2011-2.7%
Q1 2011+4.8%
Q4 2010-4.8%
Q1 2010+6.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro